Modern Wealth Management LLC Buys 363 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Modern Wealth Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,814 shares of the healthcare conglomerate’s stock after buying an additional 363 shares during the period. Modern Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,634,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. M&T Bank Corp lifted its holdings in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the period. Benjamin Edwards Inc. lifted its position in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new position in UnitedHealth Group during the third quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC lifted its holdings in shares of UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after acquiring an additional 1,051 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several analyst reports. Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Down 0.6 %

NYSE:UNH opened at $513.58 on Wednesday. The firm has a 50 day moving average of $509.10 and a 200 day moving average of $545.56. The stock has a market capitalization of $469.78 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.